$CTIX Stock | Cellceutix Corp. (CTIX) Company Research Sunday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$CTIX Cellceutix Corp. CTIX Company Overview 

Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt1=Go!

Last Updated: Sunday, November 10, 2013 2:47:04 PM

Cellceutix Corp. CTIX Current Price and Quotes
Last Price 1.83
Previous Close 1.81 Open 1.81
Daily Range 1.85 - 1.81 52wk Range 2.47 - 0.92
Volume 99,934 Dividend N/A
Average Vol (3m) 232,267 Yield N/A
Cellceutix Corp. CTIX
Company Information

100 Cumming Center
Suite 151-B
Beverly, MA 01915

Website: http://www.cellceutix.com
Phone: 978-633-3623
Email: info@cellceutix.com

Cellceutix Corp. CTIX
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Cellceutix Corp. CTIX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001355250
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 12, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees Not Available
Company Officers/Contacts

Krishna Menon President, CSO
Leo Ehrlich CFO, Interim CEO
Company Directors

Not Available
Company Notes

Formerly=EconoShare, Inc. until 2-2008
Service Providers

Auditor/Accountant
Baker Tilly Virchow Krause
One Penn Plaza
Suite 3000
New York, NY, 10119
United States

Legal Counsel
Not Available
Investor Relations Firm
E Unum Pluribus LLC

Cellceutix Corp. CTIX
CTIX Security Details

Share Structure

Market Value1 $185,779,741 a/o Nov 08, 2013
Shares Outstanding 101,518,984 a/o Sep 17, 2013
Float Not Available
Authorized Shares 300,000,000 a/o May 12, 2008
Par Value  0.0001
Shareholders

Shareholders of Record 1,700 a/o Sep 30, 2013
Short Selling Data

Short Interest 111,185 (14%)
Oct 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

West Coast Stock Transfer Inc.

Cellceutix Corp. CTIX Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 1,510 633 1,339 2,001
Sales, General and Admin. 1,473 3,564 4,383 1,363
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,983) (4,197) (5,722) (3,364)
Income From Continuing Operations

Add'l Income/Expense Items - (440) - -
Earnings Before Interest and Tax (2,983) (4,637) (5,722) (3,433)
Interest Expense 241 257 216 -
Earnings Before Tax (3,224) (4,894) (5,938) (3,433)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,224) (4,894) (5,938) (3,433)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,224) (4,894) (5,938) (3,433)
Preferred Stock and Other Adjustments (212) (66) - -
Net Income Applicable to Common Shareholders (3,436) (4,960) (5,938) (3,433)

Cellceutix Corp. CTIX Recent News

Nov 4, 2013 Cellceutix to Pursue Significant Conjuctivitis and Kerititis Ocular Markets With Novel Antibiotic Brilacidin
Oct 29, 2013 Small Cap Stocks in Focus Today are CTIX, CWGL, FNRC and DEWM
Oct 28, 2013 Cellceutix Enters Into New $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
Oct 21, 2013 Cellceutix Structures for Significant Growth in Upcoming Year
Oct 14, 2013 Cellceutix Drug Brilacidin(TM) May Be the Key Antibiotic on the Horizon for Serious Skin Infections; Plans to Start Phase 2b Study in January 2014
Oct 10, 2013 Cellceutix Antibiotic Brilacidin Chosen by Elsevier as "Top Project to Watch" in Infectious Disease
Oct 2, 2013 Cellceutix Completes Final Study to File IND Application for New Psoriasis Drug Prurisol(TM)
Sep 24, 2013 Cellceutix Plans Phase 2b Trial of New Antibiotic, Reports Fifth Cohort Complete in Novel Cancer Drug Clinical Trial
Sep 16, 2013 Cellceutix Completes Acquisition of PolyMedix Assets, Immediately Plans Brilacidin(TM) Phase 2b Clinical Trial for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Phase 2 Clinical Trial for Oral Mucositis
Sep 9, 2013 Cellceutix Acquires PolyMedix Assets From Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets

1
2
next >

CTIX Cellceutix Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CTIX/quote
Stock Chart http://www.otcmarkets.com/stock/CTIX/chart
Company Info http://www.otcmarkets.com/stock/CTIX/company-info
Recent News http://www.otcmarkets.com/stock/CTIX/news
Financials http://www.otcmarkets.com/stock/CTIX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CTIX/filings
Short Sales http://www.otcmarkets.com/stock/CTIX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CTIX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CTIX/research
Summary http://finance.yahoo.com/q?s=CTIX
Historical Prices http://finance.yahoo.com/q/hp?s=CTIX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CTIX
Basic Chart http://finance.yahoo.com/q/bc?s=CTIX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CTIX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CTIX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CTIX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CTIX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CTIX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CTIX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CTIX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CTIX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CTIX
Balance Sheet http://finance.yahoo.com/q/bs?s=CTIX
Cash Flow http://finance.yahoo.com/q/cf?s=CTIX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CTIX
Market Watch http://www.marketwatch.com/investing/stock/CTIX
Bloomberg http://www.bloomberg.com/quote/CTIX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CTIX
Bussinessweek http://investing.businessweek.com/research/st...icker=CTIX
Barchart http://www.barchart.com/quotes/stocks/CTIX
OTC Short Report http://otcshortreport.com/index.php?index=CTIX
Investopedia http://www.investopedia.com/markets/stocks/CTIX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Equity Alerts: Unraveling the Latest M&A Surprises

Updated Category News Views 0

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Continue Reading
Anita Eno: 2027's Top Trailblazing Businesswoman

Updated Category News Views 12

Anita Eno's Well-Deserved Recognition You've got to respect a story where someone claws their way up from humble beginnings to a position of serious influence. Anita Eno, Founder and CEO of Prayers Are Answered Inc., is one of those impressive figures, recently bagging the 2027 American Business Woman of the Year title. This accolade, dished out by the American Business...

Continue Reading
SINBON's Role in Sustainable Tech Showcase at 2026 Fairs

Updated Category News Views 9

Get this: What do hospitals, charging stations, and data centers have in common? Well, they all rely on data and power connections that are largely invisible but absolutely fundamental to keeping the gears of modern life grinding. SINBON Electronics is stepping up at electronica and SPS 2026, showing how their nifty gadgets transform mundane wires into the beating heart...

Continue Reading
Mili and Egnyte Transform Financial Advice Delivery

Updated Category News Views 4

AI Powers Up Financial Advisors with New Partnership Ah, the grind never ends for those financial advisors, right? Well, here's a nugget that might just lighten their load. Mili and Egnyte are buddying up to merge AI with secure content platforms, aiming to supercharge how advisors handle client documents. Right off the bat, advisors can crank out personalized advice at a...

Continue Reading
AI Traffic Sensing By AglaiaSense and Leopard Imaging

Updated Category News Views 8

Revolutionizing Traffic Sensing with Privacy The buzz in Barcelona this November is all about AglaiaSense and Leopard Imaging teaming up at the Smart City Expo World Congress. They're not just hitting exhibit after exhibit. These two are set to roll out their cutting-edge AI traffic sensing tech, and from what I'm hearing, it's miles ahead of anything we've seen before....

Continue Reading
Valens' Q3 2026 Earnings: What’s on the Horizon?

Updated Category News Views 7

Valens' Upcoming Earnings: Buckle Up, Investors! Alright folks, here’s the scoop straight from the trenches. Valens Semiconductor, ticker NYSE:VLN, is about to drop its third quarter earnings results. Mark your calendars for November 11, 2026, because that's when the numbers hit the fan. The conference call is set for a bright and early 8:30 AM ET. If you’re placing...

Continue Reading
Labcorp Scoops Up BioReference Health For $722M+

Updated Category News Views 1

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

Continue Reading
Annual Flu Shots May Save Lives: Accordia Health's Call

Updated Category News Views 0

Flu Season Isn't Just Sniffles: Accordia Health Speaks Up Listen up folks, it’s that time again and no, it ain’t just about digging out last year's scarf. Flu season is rolling in faster than a train outta hell, and already folks are talking about flu cases creeping up during the summer sunshine. We got Dr. Cameron Kilpatrick over at Accordia Health ringing the bell...

Continue Reading
Fire Safety in Focus as Lithium Battery Problem Grows

Updated Category News Views 0

Everyone’s eyeballs are glued to the burning issue of lithium-ion battery fires, and for good reason. They’re ticking time bombs, especially in those fancy new electric vehicles and gadgets. But stepping into the ring with solutions like they’re fighting windmills, Packaging and Crating Technologies (PACT®) took the spotlight at the recent Battery Show in Detroit,...

Continue Reading
Ben Felton to Lead AEIC as President for 2027

Updated Category News Views 0

A New Face at the Helm of AEIC If you’ve been keeping tabs on the utility sector, then the recent shuffling of chairs over at the Association of Edison Illuminating Companies (AEIC) might have caught your eye. They just wrapped up their 142nd Annual Meeting in Ojai, where Ben Felton from Portland General Electric stepped into the limelight as the incoming President for...

Continue Reading

Top 5 Most Recently Viewed Articles

Mike Lindell Media Corp at CPAC: A New Era in News Coverage

Updated Category News Views 122

Mike Lindell Media Corp Makes Waves at CPAC Recently, Mike Lindell Media Corp, previously known as FrankSpeech Network, Inc (OTC Pink "FSBN"), made a remarkable entrance at the CPAC event in Washington, D.C. The excitement was palpable as the team prepared to deliver extensive coverage from the convention, showcasing their commitment to providing honest and reliable news....

Continue Reading
Triumph Bancorp Achieves Record High Stock Price Performance

Updated Category News Views 155

Triumph Bancorp Stock Reaches New Heights Triumph Bancorp, Inc. (NASDAQ: TFIN) has made headlines recently as its stock price soared to an impressive 52-week high of $105.08. This milestone marks a significant achievement for the financial holding company, showcasing a remarkable increase of 49.18% in its stock value over the past year. The surge in stock price reflects...

Continue Reading
Carly E. Howard Joins CEA Industries Inc. as Non-Executive Director

Updated Category News Views 308

Carly E. Howard Joins CEA Industries Inc. Louisville, CO — CEA Industries Inc. (Nasdaq: BNC), a pioneering growth-focused company managing a significant BNB treasury, is thrilled to announce the immediate appointment of Carly E. Howard, JD, LLM, as a Non-Executive Director. Carly Howard brings over 20 years of extensive legal experience, specializing in corporate law,...

Continue Reading
Refrigerated Transport Sector Anticipated to Hit $194.2 Bn

Updated Category News Views 83

The refrigerated transport market was set for explosive growth, projected to reach USD 194.2 billion by 2032. This wasn't just idle chatter; the surge stemmed from shifting consumer preferences towards healthier eating habits, driving up demand for perishable goods like fresh produce and organic dairy. Fueling Factors Behind Market Expansion One significant driver of this...

Continue Reading
dYdX Foundation and 21Shares Discuss Future Growth and Strategies

Updated Category News Views 206

dYdX Foundation and 21Shares Discuss Future Growth and Strategies The dYdX Foundation held its first analyst call with 21Shares, where they showcased impressive performance metrics of the protocol and plans to bolster institutional adoption. Innovative Initiatives for Growth During the discussion, the Foundation revealed several exciting initiatives to increase adoption...

Continue Reading